Nitrosative damage during retrovirus infection-induced neuropathic pain

[1]  Fei Li,et al.  Flow cytometry analysis of inflammatory cells isolated from the sciatic nerve and DRG after chronic constriction injury in mice , 2017, Journal of Neuroscience Methods.

[2]  Ashutosh Kumar,et al.  Carvedilol prevents functional deficits in peripheral nerve mitochondria of rats with oxaliplatin‐evoked painful peripheral neuropathy , 2017, Toxicology and applied pharmacology.

[3]  M. Malcangio.  Spinal mechanisms of neuropathic pain: Is there a P2X4-BDNF controversy? , 2017, Neurobiology of Pain.

[4]  F. R. Nieto,et al.  Roles for CD8+ T Cells and IL-10 in the Resolution of Paclitaxel-Induced Neuropathic Pain , 2017, The Journal of Neuroscience.

[5]  Shuxian Hu,et al.  Modulation of Microglial Cell Fcγ Receptor Expression Following Viral Brain Infection , 2017, Scientific Reports.

[6]  D. Goldstein,et al.  Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy , 2017, PloS one.

[7]  Yu-Qiu Zhang,et al.  Pain regulation by non-neuronal cells and inflammation , 2016, Science.

[8]  P. Dougherty,et al.  CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain , 2016, The Journal of Neuroscience.

[9]  Shuxian Hu,et al.  Glial cells suppress postencephalitic CD8+ T lymphocytes through PD‐L1 , 2014, Glia.

[10]  D. Clifford,et al.  Peripheral neuropathy in ART-experienced patients: prevalence and risk factors , 2013, Journal of NeuroVirology.

[11]  Maiken Nedergaard,et al.  Glia and pain: Is chronic pain a gliopathy? , 2013, PAIN®.

[12]  Shuxian Hu,et al.  T-cell reconstitution during murine acquired immunodeficiency syndrome (MAIDS) produces neuroinflammation and mortality in animals harboring opportunistic viral brain infection , 2013, Journal of Neuroinflammation.

[13]  D. Bennett,et al.  Neuroinflammation and the generation of neuropathic pain. , 2013, British journal of anaesthesia.

[14]  M. Butler,et al.  Involvement of microglial CD40 in murine retrovirus-induced peripheral neuropathy , 2013, Journal of Neuroimmunology.

[15]  W. Koh,et al.  Murine Immunodeficiency Virus-Induced Peripheral Neuropathy and the Associated Cytokine Responses , 2012, The Journal of Immunology.

[16]  K. Williams,et al.  Dorsal root ganglia damage in SIV-infected rhesus macaques: an animal model of HIV-induced sensory neuropathy. , 2012, The American journal of pathology.

[17]  A. Rice,et al.  Pathogenesis of HIV‐associated sensory neuropathy: evidence from in vivo and in vitro experimental models , 2012, Journal of the peripheral nervous system : JPNS.

[18]  J. Mankowski,et al.  Macrophage-mediated dorsal root ganglion damage precedes altered nerve conduction in SIV-infected macaques. , 2011, The American journal of pathology.

[19]  Howard S. Smith,et al.  Treatment considerations in painful HIV-related neuropathy. , 2011, Pain physician.

[20]  M. Hutchinson,et al.  Peripheral immune contributions to the maintenance of central glial activation underlying neuropathic pain , 2011, Brain, Behavior, and Immunity.

[21]  Shuxian Hu,et al.  Reactive oxygen species drive herpes simplex virus (HSV)-1-induced proinflammatory cytokine production by murine microglia , 2011, Journal of Neuroinflammation.

[22]  Shuxian Hu,et al.  Memory T cells persisting in the brain following MCMV infection induce long-term microglial activation via interferon-γ , 2011, Journal of NeuroVirology.

[23]  D. Clifford,et al.  Peripheral neuropathy in HIV: prevalence and risk factors , 2011, AIDS.

[24]  Wen Li,et al.  Immunotherapy of Murine Retrovirus-Induced Acquired Immunodeficiency by CD4 T Regulatory Cell Depletion and PD-1 Blockade , 2011, Journal of Virology.

[25]  A. Rice,et al.  Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials , 2010, PloS one.

[26]  R. Dubner,et al.  Interactions between the immune and nervous systems in pain , 2010, Nature Medicine.

[27]  Jie Zhang,et al.  New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}. , 2010, Endocrinology.

[28]  F. Vaida,et al.  Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. , 2010, Archives of neurology.

[29]  Stephanie D. Kraft-Terry,et al.  A Coat of Many Colors: Neuroimmune Crosstalk in Human Immunodeficiency Virus Infection , 2009, Neuron.

[30]  T. Hulgan,et al.  Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy. , 2009, Pharmacogenomics.

[31]  M. Cheeran,et al.  Prolonged Microglial Cell Activation and Lymphocyte Infiltration following Experimental Herpes Encephalitis1 , 2008, The Journal of Immunology.

[32]  I. Vareniuk,et al.  Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes , 2008, Diabetologia.

[33]  D. Simpson,et al.  Diagnosis and management of HIV-associated neuropathy. , 2008, Neurologic clinics.

[34]  N. Jones,et al.  Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated with Increased PD-1 Expression on Effector CD8+ T Cells1 , 2008, The Journal of Immunology.

[35]  M. Cheeran,et al.  Microglia are the major cellular source of inducible nitric oxide synthase during experimental herpes encephalitis , 2008, Journal of NeuroVirology.

[36]  D. Simpson,et al.  Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axons , 2008, Experimental Neurology.

[37]  T. Okazaki,et al.  The Programmed Death-1 and Interleukin-10 Pathways Play a Down-Modulatory Role in LP-BM5 Retrovirus-Induced Murine Immunodeficiency Syndrome , 2007, Journal of Virology.

[38]  M. Cheeran,et al.  Dysregulated interferon-gamma responses during lethal cytomegalovirus brain infection of IL-10-deficient mice. , 2007, Virus research.

[39]  J. Groves,et al.  Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. , 2007, American journal of physiology. Endocrinology and metabolism.

[40]  Andrew R Segerdahl,et al.  Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. , 2007, Brain : a journal of neurology.

[41]  J. Groves,et al.  Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice , 2007, Experimental Neurology.

[42]  H. Hartung,et al.  Role of Nitric Oxide as Mediator of Nerve Injury in Inflammatory Neuropathies , 2007, Journal of neuropathology and experimental neurology.

[43]  R. Ji,et al.  p38 MAPK, microglial signaling, and neuropathic pain , 2007, Molecular pain.

[44]  A. Höke,et al.  Establishment of a Rodent Model of HIV-Associated Sensory Neuropathy , 2006, The Journal of Neuroscience.

[45]  G. Freeman,et al.  Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade , 2006, The Journal of experimental medicine.

[46]  H. Hartung,et al.  Immune circuitry in the peripheral nervous system , 2006, Current opinion in neurology.

[47]  A. Hoke,et al.  Recent advances in HIV neuropathy , 2006, Current opinion in neurology.

[48]  Philip J. R. Goulder,et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.

[49]  J. Clements,et al.  From mice to macaques--animal models of HIV nervous system disease. , 2006, Current HIV research.

[50]  P. Peterson,et al.  Microglia as a Pharmacological Target in Infectious and Inflammatory Diseases of the Brain , 2006, Journal of Neuroimmune Pharmacology.

[51]  C. Gravel,et al.  BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain , 2005, Nature.

[52]  C. Abbadie.  Chemokines, chemokine receptors and pain. , 2005, Trends in immunology.

[53]  Marshall Summar,et al.  Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study , 2005, AIDS.

[54]  S. McMahon,et al.  Role of the Immune system in chronic pain , 2005, Nature Reviews Neuroscience.

[55]  J. McArthur,et al.  Peripheral nerve-derived HIV-1 is predominantly CCR5-dependent and causes neuronal degeneration and neuroinflammation. , 2005, Virology.

[56]  Stephen B. McMahon,et al.  Immune and glial cell factors as pain mediators and modulators , 2005, Experimental Neurology.

[57]  D. Simpson,et al.  HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. , 2004, Archives of neurology.

[58]  S. Koizumi,et al.  P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury , 2003, Nature.

[59]  J. Deleo,et al.  Inhibition of Microglial Activation Attenuates the Development but Not Existing Hypersensitivity in a Rat Model of Neuropathy , 2003, Journal of Pharmacology and Experimental Therapeutics.

[60]  S. Stohlman,et al.  Kinetics of Virus-Specific CD8+-T-Cell Expansion and Trafficking following Central Nervous System Infection , 2003, Journal of Virology.

[61]  K. Marder,et al.  Incidence of and risk factors for HIV-associated distal sensory polyneuropathy , 2002, Neurology.

[62]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[63]  J. Sagen,et al.  Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis , 2001, Journal of Neuroimmunology.

[64]  R. Yezierski,et al.  The role of neuroinflammation and neuroimmune activation in persistent pain , 2001, Pain.

[65]  A. Grinberg,et al.  Increased blood–brain barrier permeability in LP-BM5 infected mice is mediated by neuroexcitatory mechanisms , 1999, Brain Research.

[66]  P. Portegies,et al.  Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. , 1999, Journal of immunology.

[67]  P. Skolnick,et al.  The Encephalopathy Associated with Murine Acquired Immunodeficiency Syndrome , 1998, Annals of the New York Academy of Sciences.

[68]  T. Takayanagi,et al.  Production of interleukin-12 and expression of its receptors by murine microglia , 1998, Brain Research.

[69]  G. Nuovo,et al.  Human immunodeficiency virus infection of dorsal root ganglion neurons detected by polymerase chain reaction in situ hybridization , 1997, Annals of neurology.

[70]  P. Shapshak,et al.  Parvalbumin and calbindin D‐28 k immunoreactivity in dorsal root ganglia in acquired immunodeficiency syndrome , 1996, Neuropathology and applied neurobiology.

[71]  W. Hickey,et al.  Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. , 1995, Journal of immunology.

[72]  P. Shapshak,et al.  Expression of HIV‐1 and interleukin‐6 in lumbosacral dorsal root ganglia of patients with AIDS , 1994, Neurology.

[73]  M. Esiri,et al.  Sensory and sympathetic ganglia in HIV-1 infection: Immunocytochemical demonstration of HIV-1 viral antigens, increased MHC class II antigen expression and mild reactive inflammation , 1993, Journal of the Neurological Sciences.

[74]  T. Molitor,et al.  Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. , 1992, Journal of immunology.

[75]  H. Morse,et al.  Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice , 1991, Journal of virology.

[76]  P. Jolicoeur.  Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[77]  D. Holtzman,et al.  Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey. , 1988, Archives of neurology.

[78]  R. Buller,et al.  CD4+ T cells are required for development of a murine retrovirus- induced immunodeficiency syndrome (MAIDS) , 1988, The Journal of experimental medicine.

[79]  H. Morse,et al.  Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice , 1985, The Journal of experimental medicine.

[80]  L. Watkins,et al.  Pathological and protective roles of glia in chronic pain , 2009, Nature Reviews Neuroscience.

[81]  G. Zanette,et al.  Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy , 2004, Acta Neuropathologica.